• $2.4M
    Market Cap
  • -73.55%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
1,868
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
-100.00%
1,868
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-1.1M
-50.23%
-2.1M
-69.16%
-6.9M
+337.40%
-1.6M
+1,824.94%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
3.2M
-23.33%
4.2M
-55.25%
9.4M
+157.24%
3.7M
+232.75%
Operating Profit
-3.2M
-23.33%
-4.2M
-55.25%
-9.4M
+157.24%
-3.7M
+232.75%
Interest Income
121,984
+119.16%
55,660
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
121,984
+119.16%
55,660
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
125,951
+18.00%
106,741
-77.74%
479,572
-78.01%
2.2M
+529.57%
Income before Taxes
-3.1M
-57.56%
-7.3M
-22.31%
-9.4M
+157.24%
-3.7M
+127.78%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-3.1M
-24.40%
-4.1M
-54.04%
-8.9M
+502.76%
-1.5M
-7.83%
Net Income from Continuing Operations Applicable to Common
-3.1M
-57.56%
-7.3M
-18.15%
-8.9M
+502.76%
-1.5M
-7.74%
Basic EPS and Net Income
-2.65
-45.13%
-4.83
-85.80%
-34.01
+26,061.54%
-0.13
-62.86%
Diluted EPS and Net Income
-2.65
-45.13%
-4.83
-85.80%
-34.01
+26,061.54%
-0.13
-62.86%
Basic Weighted Average Shares
1.2M
-22.57%
1.5M
+476.60%
263,137
N/A
N/A
N/A
Diluted Weighted Average Shares
1.2M
-22.57%
1.5M
+476.60%
263,137
N/A
N/A
N/A
Balance Sheet
Cash and Cash Equivalents
5.3M
+60.42%
3.3M
+9.86%
3.0M
-59.85%
7.5M
+12.93%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
5.3M
+60.42%
3.3M
+9.86%
3.0M
-59.85%
7.5M
+12.93%
Total Current Assets
5.8M
+50.11%
3.9M
+3.31%
3.7M
-56.00%
8.5M
+27.26%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
13,029
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
5.8M
+50.11%
3.9M
+3.31%
3.7M
-56.00%
8.5M
+27.26%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
418,587
+10.82%
377,712
-54.57%
831,402
-67.37%
2.5M
+2,450.25%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
4,670
-91.62%
55,751
-96.64%
1.7M
+632.44%
Total Liabilities
418,587
+10.82%
377,712
-54.57%
831,402
-67.37%
2.5M
+2,450.25%
Retained Earnings
-88.1M
+3.66%
-85.0M
+5.08%
-80.9M
+12.44%
-72.0M
+2.11%
Total Stockholders Equity
5.4M
+54.37%
3.5M
+19.86%
2.9M
-51.13%
5.9M
-9.55%
Total Shares Outstanding
1.8M
-39.23%
3.0M
+452.93%
534,238
-96.51%
15.3M
+47.84%
Cash Flow
Cash from Operating Activities
-2.7M
-34.76%
-4.1M
-56.83%
-9.6M
+167.90%
-3.6M
+190.33%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
4.7M
+6.26%
4.4M
-12.30%
5.0M
+13.87%
4.4M
-43.95%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
-504,727.14%
N/A
N/A
N/A
Return on Assets
-64.38%
-40.51%
-108.23%
-26.02%
-146.30%
+647.51%
-19.57%
-59.44%
Return on Equity
-70.17%
-45.48%
-128.71%
-36.33%
-202.15%
+752.56%
-23.71%
-152.38%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
13.85
+35.45%
10.22
+127.40%
4.50
+34.84%
3.33
-95.01%
Cash Ratio
12.74
+44.76%
8.80
+141.83%
3.64
+23.04%
2.96
-95.57%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow